文献速递类风湿关节炎

已确诊类风湿关节炎患者接受改善病情抗风湿药治疗后疼痛敏化变化与疾病活动度的关联

Associations Between Changes in Pain Sensitization and Disease Activity Following Disease-Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2025-07-31

研究纳入182例活动性类风湿关节炎起始或换用改善病情抗风湿药治疗的患者,观察12周。定量感觉测试显示多个解剖部位压力痛阈显著升高(改善),时间总和与条件性疼痛调制无显著变化;压力痛阈升高与DAS28-CRP、肿胀关节数、压痛关节数下降及患者总体评估改善相关,而时间总和、条件性疼痛调制与疾病活动度无显著关联。

要点

  • 12周改善病情抗风湿药治疗后多个解剖部位压力痛阈显著升高(改善)。
  • 时间总和与条件性疼痛调制在12周治疗后无显著变化。
  • 压力痛阈升高与DAS28-CRP、肿胀及压痛关节数下降、患者总体评估改善相关。

核心结论

  • 12周改善病情抗风湿药治疗后疼痛敏感性改善,且这些改善与疾病活动度下降相关。

研究设计与样本

  • 纳入182例活动性类风湿关节炎起始或换用改善病情抗风湿药治疗的患者,观察12周。
  • 采用定量感觉测试评估疼痛敏化,包括多个解剖部位的压力痛阈、腕部和前臂的时间总和及条件性疼痛调制。
  • 疾病活动度采用基于C反应蛋白的28关节疾病活动度评分及其各组分测量。
  • 采用皮尔逊相关系数和校正线性回归分析探讨定量感觉测试指标与疾病活动度指标的关联。

主要发现

  • 12周改善病情抗风湿药治疗后多个解剖部位压力痛阈显著升高(改善)。
  • 时间总和与条件性疼痛调制在12周治疗后无显著变化。
  • 多个解剖部位压力痛阈升高与DAS28-CRP下降、肿胀关节数减少、压痛关节数减少及患者总体评估改善相关。
  • 时间总和、条件性疼痛调制与疾病活动度之间无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease-modifying antirheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity. METHODS: We included 182 participants with active RA initiating/switching DMARD therapy who were observed for 12 weeks. To assess pain sensitization, participants underwent quantitative sensory testing (QST), including pressure pain thresholds (PPTs) at multiple anatomic sites, temporal summation (TS) at the wrist and forearm, and conditioned pain modulation (CPM). RA disease activity was measured using the Disease Activity Score 28 with C-reactive protein (DAS28-CRP) and its components. Mean changes in QST measures were examined from baseline to 12 weeks, and associations between QST and disease activity measures were explored using Pearson correlation coefficients and adjusted linear regression analyses. RESULTS: PPTs significantly increased (improved) at multiple anatomic sites following 12 weeks of DMARD therapy. No significant changes were observed in TS or CPM. Increased PPTs at multiple anatomic sites were associated with reductions in DAS28-CRP, swollen joint count, tender joint count, and improvements in patient global assessment. No significant associations were observed between TS, CPM, and disease activity. CONCLUSION: Pain sensitivity improved after 12 weeks of DMARD therapy. These improvements were associated with reductions in disease activity.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Aydemir B, Heisler AC, Muhammad LN, et al. Associations Between Changes in Pain Sensitization and Disease Activity Following Disease-Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis. Arthritis Rheumatol. 2025. PMID: 40432192. doi:10.1002/art.43265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。